Trial intelligence / Profile preview

Heme Arginate in Cardiac Surgery

NCT02314780Phase 2Completed

Start
Mar 2015
Primary completion
Jun 2017
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of heme arginate in reperfusion injury (IRI). Started Mar 2015; status: completed.

02

Drugs

heme arginate
03

Conditions

reperfusion injury (IRI)

Beyond the preview

Go deeper on NCT02314780.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02314780.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call